10:15am ET
Health and Healthcare
4 Top Biotech Stocks With Big Upcoming Catalysts
In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.
BMRN Coverage Page 6
11:40am ET
Health and Healthcare
Why Credit Suisse Sees 25% Upside at BioMarin
BioMarin Pharmaceutical may have missed out on the Trump rally, but it might not be too late to catch a ride on the wave, at least according to one analyst.
Chris Lange 8:40am ET
Health and Healthcare
Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential
A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.
8:25am ET
Health and Healthcare
RBC Likes Large Cap Biotech Leaders for 2017
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: GoPro, Randgold, Teva Pharma, Time Warner, Waste Management and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include GoPro, Randgold Resources, Teva Pharmaceutical, Time Warner, Waste Management.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK Partners and Sunrun.
10:35am ET
Health and Healthcare
Top Health Care Earnings Coming Next Week
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
8:20am ET
Health and Healthcare
3 Biotech Stocks Could Be the Next Big Takeover Targets
In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative takeover targets, and a third is a possible target as well.
10:40am ET
Health and Healthcare
Merrill Lynch Says the Time to Put Money Into Biotech Is Now
Though these four large cap biotech stocks are cheap relative to the S&P 500, history says they won’t stay that way.
8:20am ET
Health and Healthcare
JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now
A new JPMorgan research report says it time to buy the health care sector and sell consumer staples, which have run hard this year.
9:45am ET
Health and Healthcare
4 Major FDA Decisions Expected by June
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.
10:50am ET
Health and Healthcare
Analysts Make Major Changes to Top Biotech Ratings
With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls by the week's end.
10:05am ET
Health and Healthcare
4 Biotechs That Will Escape Weak Seasonal Trends for the Sector
Typically each year, the first quarter is the slowest for biotech stocks. SunTrust Robinson Humphrey has four stocks rated Buy that should come in fine when numbers are released.
11:05am ET
Health and Healthcare
Can BioMarin Make Treating Hemophilia More Affordable?
BioMarin Pharmaceutical is ready to break above the $1 billion revenue barrier in 2016, a feat that marks a major hurdle for many biotech and emerging pharmaceutical companies.
Jon C. Ogg